Jelena Prljic

Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors

Draginja Radošević, Milan Senćanski, Vladimir Perović et al. · Frontiers in Cellular and Infection Microbiology · 2019 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

EMILINs interact with anthrax protective antigen and inhibit toxin action in vitro

Roberto Doliana, Veljko Veljković, Jelena Prljic et al. · Matrix Biology · 2007 · 25 citations

Life Sciences, Immunology, Pharmacology +15

Design of peptide mimetics of HIV‐1 gp120 for prevention and therapy of HIV disease

Nevena Veljković, Donald R. Branch, Radmila Metlaš et al. · Journal of Peptide Research · 2003 · 17 citations · Full text

Pharmacy, Immunology, Molecular Biology +17

Lipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular disease

Sanja Glišić, Patrizio Arrigo, Dragan Alavantić et al. · Proteins Structure Function and Bioinformatics · 2007 · 17 citations

Life Sciences, Biochemistry, Bioinformatics +16

Evolution of 2014/15 H3N2 Influenza Viruses Circulating in US: Consequences for Vaccine Effectiveness and Possible New Pandemic

Veljko Veljković, Slobodan Paessler, Sanja Glišić et al. · Frontiers in Microbiology · 2015 · 13 citations · Full text

Life Sciences, Bioinformatics, Immunology +13